Pro Medicus Limited (ASX:PME – Get Free Report) insider Alice Williams bought 125 shares of Pro Medicus stock in a transaction on Friday, February 14th. The shares were purchased at an average price of A$272.69 ($172.59) per share, for a total transaction of A$34,086.00 ($21,573.42).
Pro Medicus Stock Performance
The company has a debt-to-equity ratio of 1.10, a current ratio of 5.98 and a quick ratio of 4.39. The firm has a market capitalization of $29.16 billion, a price-to-earnings ratio of 351.99, a P/E/G ratio of 3.87 and a beta of 0.56.
Pro Medicus Increases Dividend
The company also recently announced a Interim dividend, which will be paid on Thursday, March 20th. Shareholders of record on Thursday, March 20th will be issued a dividend of $0.25 per share. This is an increase from Pro Medicus’s previous Interim dividend of $0.18. The ex-dividend date is Wednesday, February 26th. This represents a dividend yield of 0.09%. Pro Medicus’s dividend payout ratio is 56.41%.
About Pro Medicus
Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers Visage radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform.
Featured Articles
- Five stocks we like better than Pro Medicus
- Short Selling: How to Short a Stock
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- Technology Stocks Explained: Here’s What to Know About Tech
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- What Are Treasury Bonds?
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Receive News & Ratings for Pro Medicus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro Medicus and related companies with MarketBeat.com's FREE daily email newsletter.